[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336750-105":59,"doc-detail-336750-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","effects-of-t2dm-on-cancer-progression-pivotal-precipitating-factors-and-underlying-mechanisms","Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms","","Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder featuring hyperinsulinemia, hyperglycemia, hyperlipidemia, and dysbiosis. Epidemiologic evidence links T2DM with increased cancer development and progression. Hyperinsulinemia and hyperglycemia promote tumor growth by activating mitogenic pathways, while dyslipidemia contributes to a pro-tumor environment through chronic inflammation and oxidative stress. This review synthesizes epidemiologic associations and clarifies molecular mechanisms that may guide therapeutic target discovery for T2DM-related malignancies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/effects-of-t2dm-on-cancer-progression-pivotal-precipitating-factors-and-underlying-mechanisms/336750/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/effects-of-t2dm-on-cancer-progression-pivotal-precipitating-factors-and-underlying-mechanisms/336750.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What key T2DM-related features are discussed as drivers of cancer progression?","Question",{"text":112,"@type":113},"The review focuses on hyperinsulinemia, hyperglycemia, and hyperlipidemia, alongside their systemic context in T2DM.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does hyperglycemia contribute to cancer progression?",{"text":117,"@type":113},"Hyperglycemia supports cancer cell proliferation by providing readily available glucose that fuels rapid cell division.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic direction does the review aim to support?",{"text":121,"@type":113},"It aims to identify potential therapeutic targets for T2DM-related malignancies and outline directions for future investigation of underlying mechanisms.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336750,1790380195,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","TYPE Review  \nPUBLISHED 03 September 2024 DOI 10.3389/fendo.2024.1396022  \nOPEN ACCESS  \nEDITED BY  \nPeiyuan Yin,  \nDalian Medical University, China  \nREVIEWED BY Rishat Ruzi,  \nFirst Afﬁliated Hospital of Xinjiang Medical University, China  \nPriyanka Singh,  \nIndian Institute of Technology Jodhpur, India  \n*CORRESPONDENCE Yong-Jiang Li  \n [yongjiangli@dlut.edu.cn](yongjiangli@dlut.edu.cn)[ ](yongjiangli@dlut.edu.cn)Zheng-Nan Gao  \n [gao2008@dlut.edu.cn](gao2008@dlut.edu.cn)  \nRECEIVED 05 March 2024  \nACCEPTED 21 August 2024  \nPUBLISHED 03 September 2024  \nCITATION  \nZhang Y-Y, Li Y-J, Xue C-D, Li S, Gao Z-Nand Qin K-R (2024) Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms.  \nFront. Endocrinol. 15:1396022 .  \ndoi: 10.3389/fendo.2024.1396022  \nCOPYRIGHT  \n© 2024 Zhang, Li, Xue, Li, Gao and Qin. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nEffects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms  \nYu-Yuan Zhang1,2, Yong-Jiang Li 1,2*, Chun-Dong Xue 1,2, Shen Li 1, Zheng-Nan Gao 1* and Kai-Rong Qin 1,2  \n1 Institute of Cardio-Cerebrovascular Medicine, Central Hospital of Dalian University of Technology, Dalian, Liaoning, China, 2School of Biomedical Engineering, Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning, China  \nType 2 diabetes mellitus (T2DM) is a chronic metabolic disorder affecting people worldwide. It is characterized by several key features, including hyperinsulinemia, hyperglycemia, hyperlipidemia, and dysbiosis. Epidemiologic studies have shown that T2DM is closely associated with the development and progression of cancer. T2DM-related hyperinsulinemia, hyperglycemia, and hyperlipidemia contribute to cancer progression through complex signaling pathways. These factors increase drug resistance, apoptosis resistance, and the migration, invasion, and proliferation of cancer cells. Here, we will focus on the role of hyperinsulinemia, hyperglycemia, and hyper lipidemia associated with T2DM in cancer development. Additionally, we will elucidate the potential molecular mechanisms underlying their effects on cancer progression. We aim to identify potential therapeutic targets for T2DM-related malignancies and explore relevant directions for future investigation.  \nKEYWORDS  \nT2DM, cancer, molecular mechanism, hyperinsulinemia, hyperglycemia, hyperlipidemia  \n1 Introduction  \nType 2 diabetes mellitus (T2DM) is a chronic metabolic disorder primarily characterized by insulin resistance and relative insulin deﬁciency (1) . This condition leads to persistent hyperglycemia (2–4) . T2DM accounts for approximately 90% of all diabetes cases worldwide. It is often associated with various systemic complications, including cardiovascular disease, nephropathy, neuropathy, and retinopathy (3, 4) . Hyperglycemia is a hallmark of T2DM, resulting from the body’s inability to efﬁciently use glucose due to impaired insulin action (5–10) . This chronic elevation of blood glucose levels is a key factor in the development of T2DM-related complications (9–11) .  \nIn addition to hyperglycemia, T2DM is often associated with hyperinsulinemia. This condition is an early compensatory response to insulin resistance, where the pancreas produces  \nFrontiers in Endocrinology 01 [frontiersin.org](frontiersin.org)  \nmore insulin to overcome reduced insulin sensitivity (12, 13). Overtime, hyperinsulinemia can lead to pancreatic b-cell dysfunction, further exacerbating hyperglycemia. T2DM is also linked with dyslipidemia, characterized by elevated levels o","cbCair9zDDBjcGj0","https://ap.wps.com/l/cbCair9zDDBjcGj0","pdf",5608487,16,"English","# Introduction\n# Epidemiological association between T2DM-related features and cancer","[{\"question\":\"What key T2DM-related features are discussed as drivers of cancer progression?\",\"answer\":\"The review focuses on hyperinsulinemia, hyperglycemia, and hyperlipidemia, alongside their systemic context in T2DM.\"},{\"question\":\"How does hyperglycemia contribute to cancer progression?\",\"answer\":\"Hyperglycemia supports cancer cell proliferation by providing readily available glucose that fuels rapid cell division.\"},{\"question\":\"What therapeutic direction does the review aim to support?\",\"answer\":\"It aims to identify potential therapeutic targets for T2DM-related malignancies and outline directions for future investigation of underlying mechanisms.\"}]","Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms | PDF",1790016450,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6e39f140ecc167ec6c709b19347b48c.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5b9e0c2b16b7302e27fa8c516664bfc.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ee7b3c449ac7dfd541a7b4945c5610e.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/825bb8f43d8b20a24debb2efad69a8c9.webp",980,1385]